Ultrasound Imaging and Doppler Studies of the Placenta

Tuuli, Methodius G.; Odibo, Anthony O.

doi:10.1002/9781444393927.ch16

Cited by 2 publications

(2 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Detailed sonographic evaluation of the placenta and histopathological confirmation after birth are used to identify lesions associated with preeclampsia, intrauterine growth restriction and adverse short and long-term perinatal outcome [25, 50-58]. The presence of cystic images in the placenta is not uniformly associated with adverse perinatal outcome [59].…”

Section: Commentmentioning

confidence: 99%

Prenatal Diagnosis of a Placental Infarction Hematoma Associated with Fetal Growth Restriction, Preeclampsia and Fetal Death: Clinicopathological Correlation

et al. 2014

View full text Add to dashboard Cite

The lesion termed ‘placental infarction hematoma' is associated with fetal death and adverse perinatal outcome. Such a lesion has been associated with a high risk of fetal death and abruption placentae. The fetal and placental hemodynamic changes associated with placental infarction hematoma have not been reported. This paper describes a case of early and severe growth restriction with preeclampsia, and progressive deterioration of the fetal and placental Doppler parameters in the presence of a placental infarction hematoma.

show abstract

Section: Commentmentioning

confidence: 99%

Prenatal Diagnosis of a Placental Infarction Hematoma Associated with Fetal Growth Restriction, Preeclampsia and Fetal Death: Clinicopathological Correlation

et al. 2014

View full text Add to dashboard Cite

show abstract

“…It is also difficult to conduct thorough research within this field as randomised controlled trials would not be ethical. 31 Consequently, it is difficult to conclude whether it is clinically justified to perform screening for vasa praevia as a technique and management strategy is not clearly defined. What is apparent though is that when a prenatal diagnosis is made, follow-up is important to assess for resolution of the condition.…”

Section: Resultsmentioning

confidence: 99%

Is ultrasound screening for vasa praevia clinically justified and a financially viable screening test? A literature review

Gillian

Venables

2018

Ultrasound

View full text Add to dashboard Cite

Vasa praevia is an obstetric complication currently not screened for within the United Kingdom, which if undetected prenatally can lead to fetal death when the membranes rupture. Internationally, guidelines are available providing guidance on the best screening policy and management pathways. However, the UK National Screening Committee and Royal College of Obstetricians and Gynaecologists do not support screening due to a lack of evidence. Recent studies explore the ability of ultrasound to detect vasa praevia prenatally in both the general and high-risk populations. Whilst there is no consensus on the 'best' screening strategy, the majority of authors note that targeted screening of the high-risk population is the most achievable and cost-effective strategy. Although not infallible, a standard screening protocol could identify the majority of cases in the high-risk group. Introduction of a screening strategy would affect training needs of professionals within the UK and would have implications on the need to produce guidelines on management and quality assurance. Further research is also needed to define a relevant high-risk population and explore how this would impact on service provision. This review explores the current evidence base for systematic screening and the implications for service.

show abstract

Ultrasound Imaging and Doppler Studies of the Placenta

Cited by 2 publications

References 14 publications

Prenatal Diagnosis of a Placental Infarction Hematoma Associated with Fetal Growth Restriction, Preeclampsia and Fetal Death: Clinicopathological Correlation

Prenatal Diagnosis of a Placental Infarction Hematoma Associated with Fetal Growth Restriction, Preeclampsia and Fetal Death: Clinicopathological Correlation

Is ultrasound screening for vasa praevia clinically justified and a financially viable screening test? A literature review

Contact Info

Product

Resources

About